Laboratory medicine is the single highest volume medical activity in healthcare and demand for laboratory testing is increasing disproportionately to medical activity. It has been estimated that $6.8 billion of medical care in the US involves unnecessary testing and procedures that do not improve patient care and may even harm the patient. Physicians face many challenges in accurately, efficiently and safely ordering and interpreting diagnostic tests. In order to improve patient outcomes, laboratory tests must be appropriately ordered, properly conducted, reported in a timely manner, correctly interpreted and affect a decision for future diagnosis and treatment of the patient. This paper discusses factors influencing test ordering by physicians, strategies for modifying physicians' ordering patterns, and ways to implement policies to improve laboratory utilization and thereby improve patient outcome.
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Laboratory medicine is the single highest volume medical activity in healthcare and demand for laboratory testing is increasing disproportionately to medical activity. Over the past 20 years, the number of laboratory tests available to clinicians has more than doubled, to at least 3,500 tests (1) . The global IVD market, valued at $49 billion in 2012, is expected to grow by 7% over the period 2012-2017, and represents 3-5% of all healthcare costs (2) .
A major component of US healthcare expenditure is an estimated $65 billion spent each year to perform more than 4.3 billion laboratory tests (3) but it has been estimated that $6.8 billion of medical care in the US involves unnecessary testing and procedures that do not improve patient care and may even harm the patient (4) . Physicians face many challenges in accurately, efficiently and safely ordering and interpreting diagnostic tests. (The term 'ordering' will be used throughout this paper for consistency. However, tests are 'requested', not 'ordered' in many countries, and 'requesting' better reflects the collaboration between clinician and laboratory). To improve patient outcomes, laboratory tests must be appropriately ordered, properly conducted, reported in a timely manner, correctly interpreted and affect a decision for future diagnosis and treatment of the patient (5) .
However, the use of laboratory diagnostics varies between countries and in the US it was 5 times greater (as a proportion of medical expenditure) than in the UK in 2006 (2). Large differences between individual practitioners in laboratory utilization have been reported in several countries (6) (7) (8) (9) The recent publication in England of the 'National Health Service Atlas of Variation' (10) demonstrated the variation in ordering rates for diagnostic tests across 151 primary care organizations. There may be valid reasons to explain some of the observed variation, such as different populations or case mix, incidence of deprivation, disease prevalence, local policy decisions on specific services and the availability of relatively new or high-technology tests. However, despite these factors, the variation in ordering rates is so large that it must reflect considerable differences in the individual ordering patterns of doctors within each primary care organization. An example is shown in Figure 1 for B-type natriuretic peptide (BNP). This test has been advocated for many years as a first line screening test for patients with symptoms of heart failure. UK national guidance commends its use (11) and recommends that the test is used to support the decision-making process as to whether a patient should be referred for echocardiography and/or to a specialist cardiologist. Figure 1 shows an 89-fold difference in ordering rates for BNP between different primary care organizations. This may represent failure of guideline uptake or the unavailability of the test in some areas due to cost pressures. Variation in utilization of this test can have a real impact on patient care and subsequent morbidity and mortality.
There are many factors which determine a physician's test ordering practices. In literature surveys (12, 13) , physicians mostly cite fear of legal (malpractice) complaints as the primary driver of over-testing. A recent article by Hoffman et al. (14) states that the main driver of over-diagnosis and over treatment is zero tolerance for error and uncertainty. Addressing the widespread intolerance of uncertainty requires a cultural change both within the medical profession and by the public. This paper will examine the following:
• Factors influencing test ordering by physicians;
• Strategies for modifying physicians' ordering pattern;
• Ways to implementing policies to improve laboratory utilization and thereby improve patient outcome. 
FACTORS INFLUENCING TEST ORDERING BY PHYSICIANS
Users of the clinical laboratory want information to allow them to make better decisions about patients. They want to be assured that the investigations they order will be quick, accurate and inexpensive and they want 'new' tests to be readily available. They want to be able to do the right investigation on the right patient at the right time, with results reaching the right clinician at the right time and in the right format and medium. In addition, availability of the right interpretation is essential to ensure the optimum patient outcome. Hopefully, the clinician is also concerned with patient safety, clinical accountability and clinical governance.
However, the clinician faces huge problems in getting test ordering right. There are too many tests, they have different names, they are reported in different units, there are different reference intervals between laboratories, there are different decision limits and guidelines are often inconsistent. Clinicians want tests with high diagnostic accuracy, good predictive value and proven clinical utility in decision making.
Two literature reviews (15, 16) e. External barriers such as resource availability, practice constraints and lack of time.
There have been several national initiatives to try to reduce over-diagnosis and change physician behaviour and adherence to guidance. In the UK, these include the NICE initiative of a 'do not do' recommendation database, comprising tests or procedures with limited or no value that should not be used (23). In the US, the 'Choosing Wisely' campaign (24) aims to help healthcare practitioners, patients and other stakeholders develop sustainable solutions to stop the overuse and misuse of medical tests and procedures that provide little or no benefit. In addition, a group from the Australian Government Department of Health identified potentially unsafe, ineffective or inappropriate services listed on the country's Medicare Benefit Schedule (25).
The US National Physician Alliance (NPA) have created a project entitled 'Promoting good stewardship in clinical practice' that aimed to develop a list of the top five activities in family medicine, internal medicine and paediatrics where the quality of care can be improved. As part of the list for internal medicine, they recommended not obtaining blood chemistry panels or urinalysis for screening asymptomatic healthy adults, and only screening for type II diabetes mellitus in asymptomatic adults with hypertension (26) .
Improving adherence to clinical guidelines requires targeting, proper dissemination and education. As we will see later, there is considerable overlap between successful implementation of guidelines or strategies and improving ordering behaviour. Guidelines should be written, published and disseminated, but it is essential that proper implementation strategies are devised and delivered, as implementation is crucial to ensuring a positive impact on patient outcome.
INAPPROPRIATE LABORATORY UTILIZATION
An analysis of 307 malpractice claims in the US (27) studied the principal areas of faulty processes which led to misdiagnosis in patients. The top cause, found in 55% of patients, was the failure to order the appropriate diagnostic/ laboratory test. There is growing recognition that errors in test selection (inappropriate ordering) and result interpretation can have significant or adverse clinical consequences to patients and financial consequences to healthcare institutions (28).
As Moynihan et al. (29) have written, "Medicine's much heralded ability to heal the sick is fast being challenged by its propensity to harm the healthy. Too many people are being
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over-dosed, over-treated and over-diagnosed." They state that $200 billion may be wasted on unnecessary treatment every year in the US, for example screening programmes detecting early cancers that will never cause symptoms or death.
Five per cent of all healthy patients will get abnormal test results and false findings or trivial abnormalities can lead to unnecessary further testing and expensive and potentially risky interventions, leading to poor patient outcomes. Causes of over-utilization include patient pressure, duplicate ordering, lack of understanding of the diagnostic value of a test, ordering the wrong test, failure to understand the consequences of over-utilization, defensive testing, perverse financial incentives and 'availability creates demand' (where the key driver is technological advance). Some of the consequences of over-utilization include incorrect diagnosis and treatment, incorrect test ordering which delays the actual diagnosis, increased length of hospital stay, unnecessary blood loss, increased resource utilization and, most important, unnecessary patient alarm.
Moynihan et al. (29) point out that the concern about over-diagnosis does not preclude awareness that many people miss out on much needed healthcare. In fact resources wasted on unnecessary diagnoses and care can be much better spent treating and preventing genuine illness.
Van Walraven and Naylor, in their systematic review in1998 (30) There is often little thought given to the patient's views and the non-clinical outcomes.
A reduction in inappropriate ordering will reduce the need for some phlebotomy episodes and reduce the associated discomfort and inconvenience such as time off work, as well as minimizing potential patient anxiety. It must be recognised that inappropriate testing will impact on follow-up, by leading to false positive results, and unnecessary further interventions such as referral and further invasive investigations.
There is no point in ordering a test if no-one looks at the results and/or acts on them. Table 1 .
Astion has described the factors he feels improve laboratory utilization (37) . He describes both physician education and patient education as weak interventions in isolation. CPOE can improve laboratory utilization if thoughtfully implemented and education can be made more effective by combining it with other methods that make the desired behaviour more likely, including CPOE, use of formularies, implementing higher levels of approval for some tests and the use of physician utilization reports with performance feedback. As in many other studies, the best approach to improving laboratory utilization combines multiple interventions (17) .
It is imperative that these interventions remain in place, or ordering behaviour will drift back to the initial condition. In a cluster randomized trial by Thomas et al. (38) , the effect of enhanced feedback and brief educational reminder messages on 9 tests ordered in primary care over a 12 month period achieved a reduction of around 10% in the number of orders when used alone but when the initiatives were used together (in combination) they demonstrated a larger reduction -greater than 20% of total tests ordered. Figure 2 shows the 'test cycle' and highlights the points at which the laboratory clinicians can become engaged in managing appropriate test utilization. The patient must always be the focus of all processes and outcomes.

MEDICAL EDUCATION
One of the biggest areas of concern is the level of education of junior doctors (interns) about laboratory medicine, which has decreased in many countries. Khromova and Gray (39) surveyed junior medical staff in Sheffield and found they lacked confidence in both ordering and interpreting basic clinical chemistry tests, such as serum protein, magnesium and phosphate. Up to 75% of the junior doctors felt they needed further teaching in A survey by Laposata (28) showed that every US medical school teaches more than 100 hours of anatomic pathology, whilst only 9% have a separate and distinct course in laboratory medicine. The mean time spent teaching medical students on the appropriate selection of laboratory tests and the correct interpretation of results over the entire 4 year curriculum was 10 hours and it was less than 5 hours in many of the institutions. The survey showed that completion of anatomic pathology training required passing an examination, but there were no examinations for laboratory medicine, despite it forming a much greater part of the experience of most physicians. 
HARMONIZATION OF NOMENCLATURE
CLIHC have also examined the issue of the wide inconsistencies in test nomenclature as a significant barrier to physicians ordering the correct test. For example, there are at least 18 different titles for vitamin D related tests in the US. In the UK, the National Laboratory Medicine Catalogue (NLMC) has the long-term objective that each test 'name' represents a single pathology test concept and each concept is represented by just one name. The NLMC aims to standardize ordering, reporting and analysing of pathology tests to ensure that the right patient gets the right test at the right time. There is a standardized list of pathology tests that have been validated for use within the UK NHS. This list is provided in an XML format and may be used within Laboratory Information Management Systems (LIMS),
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electronic patient records and pathology order communications (44).
HARMONIZING COMMON LABORATORY TEST PROFILES
A common source of physician confusion is that different laboratories provide different 'profiles' of tests to answer the same clinical question. This variation is often for historical reasons. In the UK, it has been revealed by a national pathology benchmarking initiative (45) , which showed 12 different profiles for liver function tests among 50 laboratories subscribing to the initiative. As a consequence, the UK Association for Clinical Biochemistry and Laboratory Medicine, have produced proposals for a consensus view on profile composition, e.g. liver panel: bilirubin, alanine transaminase, alkaline phosphatase, albumin (46). As well as removing confusion, harmonizing profiles can save money and reduce further investigations instigated as a result of clinically irrelevant minor abnormalities in irrelevant tests.
Laboratories must increase their efforts to engage with the test user to provide the appropriate tests in any clinical situation, whatever the core profiles contain.
COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)
CPOE can be a blessing or a curse, depending on how it is implemented. The worst case scenario is an electronic test order form in which the full menu of laboratory tests, from the most common to the most esoteric is made readily available to all practitioners, and repetitive interval-based testing (e.g. daily thyroid function testing) is easy to instigate. This is a recipe for laboratory mis-utilization, and the laboratory involved would have to bear responsibility for the resulting situation.
If CPOE is implemented with a strategy that prompts physicians with relevant information at the time of test ordering, it has been shown to decrease utilization of some commonly ordered tests in the in-patient setting. In one study, physicians were prompted electronically as to whether they wanted to continue their daily metabolic panel order after the patient had been in hospital for 72h (47) . The effect of this was to reduce testing by 24% with no change in patient outcome. Design of the electronic order form is crucial: following literature searches showing that gamma-glutamyl transferase (GGT) need not form part of the routine liver panel, local experience of removing the GGT tick box for a 12 month period during 2010/2011 reduced GGT ordering by almost 50% (unpublished data).
As yet, there is limited published evidence on the impact of CPOE on clinical outcomes. However, the potential of the approach has been investigated in the context of imaging (48) . It was proposed that a system linking electronic ordering of imaging orders to best practice diagnostic pathways represented the way to maximize appropriate referrals.
A systematic review in 2006 identified 19 studies of the impact of CPOE on laboratory testing (49) . Eleven of these compared CPOE (with and without decision support) to no CPOE for laboratory testing in a range of countries (South Korea, USA, UK, Canada, Norway), and eight studies compared CPOE with and without specific decision support (all in USA). Eight of the first group of studies and all of the second group considered outcomes that could be specifically related to appropriateness issues such as clinical indicators, length of stay or appropriateness of stay. The CPOE systems (both with and without decision support) showed an overall trend towards reduced test volume and cost, when compared to no CPOE. Overall, fewer tests and (when measured) fewer inappropriate tests were performed in the decision support group.
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In addition, the decision support group showed a significant reduction in the median time to appropriate treatment for critical results reported in one of the randomized controlled trials.
Four of the studies found that CPOE systems combined with decision support improved adherence to guidelines provided on the system. One of the advantages of CPOE is the ability to link electronically to relevant knowledge resources, but care is needed not to make the ordering process unwieldy.
In a UK study of implementation of CPOE (50), it was shown to be associated with a reduction in the proportion of outpatient appointments at which full blood count, urea and electrolytes and urine culture tests were ordered and at which full blood count tests were repeated. However, the system was associated with an almost 4-fold increase in the use of urea and electrolytes testing amongst day case patients.
A recent publication from Turner et al. (51) looked at pre-analytical errors from primary care during two six-month periods pre-and post-implementation of electronic ordering. Outcomes measured included whether there was correct information on the sample, whether the correct sample was received and whether clinical history was provided. There was a marked decrease in the number of pre-analytical errors following the introduction of electronic ordering (2764 pre-implementation versus 498 post-implementation). The error rate dropped across all general practices: pre-implementation error rates ranged up to 5.7% of orders, post-implementation error rates were less than 0.6% (56) . These approaches improved the diagnosis of hypovitaminosis D, hypomagnesaemia, hypothyroidism, hyperthyroidism and haemochromatosis, improving both the clinical utility of the laboratory service and the patient outcome.
PROVIDING COST INFORMATION ON LABORATORY TEST ORDERING
Healthcare budgets worldwide are facing increasing pressure to reduce costs and improve efficiency whilst maintaining quality. Pathology investigations cost the UK National Health Service £2.5 billion per year. A review commissioned by the UK Department of Health estimated that 20% of this could be saved by improving utilization of pathology services, despite the annual increase of 8-10% in workload.
The review estimated that 25% of pathology tests were unnecessary, representing a huge potential waste of resource (57).
A controlled clinical trial at John Hopkins' Hospital displayed 'fees' for 61 random laboratory tests in their CPOE. In the 'active arm', there was an 8.59% decrease in the number of tests per patient. In the 'control arm', there was a 5.64% increase (58).
In a similar study involving 215 primary care physicians in Massachusetts, Medicare reimbursement rate for 27 laboratory tests was displayed. In the intervention group there was a significant decrease of 19% in ordering rates compared to control physicians for 5 tests. In addition, the majority (81%) of physicians reported that the intervention improved their knowledge of the relative cost of laboratory tests (59).
CONCLUSION
Successful management of laboratory test utilization requires the entire laboratory team to use their skills and knowledge to identify utilization issues, implement a programme that will achieve more effective laboratory testing and establish appropriate processes from the beginning to the end of the test cycle. This is not easy and requires interactions with our clinical colleagues that some laboratory workers may find uncomfortable -questioning clinicians, and advising that they should not order a particular test but another test is more appropriate. Generally, clinicians have few direct incentives to restrict laboratory utilization, and are not being trained to do so. It is disappointing that there is so little literature on the effectiveness of appropriate test utilization on patient outcomes, as well as on cost effectiveness across the whole patient pathway.
"We need to recognise that the target of requesting of the test and of the results should be the patient. 60. Goetz T. The decision tree: taking control of your health in the new era of personalized medicine. Emmaus, PA: Rodale Books, 2010.
